Syensqo USA LLC

Lawrence, NJ ManufacturingNAICS 325900

Self-funded health planPlan year 2025Renews January
4,133Participants-14% vs. prior year
$9.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#19 of 76Manufacturing in NJBy participants

Overview

Syensqo USA LLC sponsors a self-funded health plan that covered 4,133 participants in plan year 2025, down 14% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
4,133 · prior year 4,817
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Syensqo USA Retiree Medical & Life Insurance Plan, plan 510 (4,133 participants)
Stop-loss carrier
Tokio Marine HCC
Broker compensation
$654K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyLife, Long-term disability, Short-term disability5,060$10.9M$456K
Kaiser Foundation Health Plan Inc.Medical, Prescription drug, HMO317$2.6M—
Cigna Health and Life Insurance CompanyCritical Illness, Hospital Care, Accidental Injury1,227$718K$183K
Cigna Health and Life Insurance Company and AffiliatesVision1,992$153K—
MetLife Legal PlansLegal663$144K$15K
Tokio Marine HCCStop-loss4,314$49K—
Workplace OptionsEmployee Assistance Program868$10K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$9.8M/ year

Estimated prescription spend: 4,133 participants × $2,371 national average per member. Usually higher once dependents are counted.

$255K–$628K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$74K–$186K
Lower-cost therapeutic alternatives$109K–$227K
Generic pricing vs. actual cost$47K–$141K
PBM contract terms$24K–$73K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Syensqo USA LLC
Sponsor EIN
22-3539954
Plan number
510
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 22-3539954 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Syensqo USA 401(k)plan
Type
401(k) plan
Participants
8,561

About this data

Source: Syensqo USA LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Syensqo USA LLC.

Request a correction · Methodology